Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus

Study Overview
=================
Brief Summary
-----------------
This study evaluates the overall cardiovascular risk status and best predictors of optimal metabolic control of Turkish adult patients with diabetes mellitus.

Detailed Description
-----------------
Diabetes mellitus is one of the most common chronic diseases with an increasing prevalence worldwide.The prevalence of diabetes is also increased significantly in Turkey, from 7.2 % in 2002 to 13.7% in 2012.This increasing prevalence leads to serious public health problems and a significant economic burden. Therefore, the optimal treatment of diabetes and prevention of diabetic complications, especially the cardiovascular outcomes, is utmost important. Although achieving glycemic targets in patients with diabetes is of great importance, blood glucose is not the only predictor of cardiovascular outcome in diabetes. Optimization of other metabolic parameters such as lipids, arterial blood pressure (ABP), and body weight as well as a healthy lifestyle are utmost important. As there is hardly enough data about glycemic and other metabolic control parameters in Turkish adult patients with type 1 or type 2 diabetes, this nationwide survey was performed.

Official Title
-----------------
Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus (TEMD Study)

Conditions
-----------------
Diabetes Mellitus

Intervention / Treatment
-----------------
* Other: There is no intervention.


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients with type 1 or type 2 diabetes Upper than 18 years old To be under follow-up in the same center for at least one year. Exclusion Criteria: Pregnancy Younger than 18 years old, History of decompensated liver disease, History of psychiatric disorders interfering cognition or compliance History of bariatric surgery History of renal replacement therapy.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with diabetes mellitus<br>Patients with type 1 or type 2 diabetes who were under follow-up in the same center for at least a year. | Other: There is no intervention.<br>* There is no intervention.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Glycemia control status of Turkish adult patients with diabetes mellitus | Glycemia control will be defined as good control if the mean HbA1c level of patients < 7% or poor control if the mean HbA1c level of patient > 7% | 7 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Blood pressure control status of Turkish adult patients with diabetes mellitus | Home blood pressure <135/85 mmHg will be defined as under control. | 7 days | 
| Lipid control status of Turkish adult patients with diabetes mellitus. | Triglyceride < 150 mg/dl, LDL-C < 100 mg/dl, HDL-C > 40 mg/dl for men, and HDL-C > 50 mg/dl for women will be defined as under control. | 7 days. | 
| Weight control status of Turkish adult patients with diabetes mellitus. | Body mass index < 30 kg/m2 will be defined as under control. Weight and height will be combined to report body mass index in kg/m2. | 7 days. | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Cardiovascular risk status, Optimal metabolic control